Renal Artery Denervation for the Management of Hypertension: Current Trends and Future Direction

被引：1

作者：

Naqvi, Syed Yaseen

Shah, Muhammad Usman ^{[1
,2
]}

Renner, Mandy

Kouloumpinis, Alexandros

Qamar, Muhammad Jawad Ul

Ali, Ali

Goldberg, Sheldon

Thackray, Simon

机构：

[1] Hull Univ Teaching Hosp, Castle Hill Hosp, Dept Cardiol, Cottingham, England

[2] Univ Lincoln, Sch Life Sci, Lincoln LN6 7DL, England

来源：

AMERICAN JOURNAL OF MEDICINE | 2024年 / 137卷 / 12期

关键词：

Blood pressure; Hypertension; Interventional cardiology; Renal artery denervation; Review article; Sympathetic nervous system; TREATMENT-RESISTANT HYPERTENSION; UNCONTROLLED HYPERTENSION; ANTIHYPERTENSIVE MEDICATIONS; SYMPATHETIC DENERVATION; TRIAL; MODERATE; ABSENCE; DESIGN; RATIONALE;

D O I：

10.1016/j.amjmed.2024.06.029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Renal artery denervation has re-emerged as a potential therapeutic option for patients with hypertension, especially those resistant to conventional pharmacotherapy. This comprehensive review explores the importance of careful patient selection, procedural techniques, clinical efficacy, safety considerations, and future directions of renal artery denervation in hypertension management. Drawing upon a wide range of available evidence, this review aims to provide a thorough understanding of the procedure and its role in contemporary hypertension treatment paradigms. (c) 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) The American Journal of Medicine (2024) 137:1190 - 1199

引用

页数：14

共 50 条

[41] Ultrasound renal denervation for hypertension: impact of the RADIANCE-HTN-TRIO trial on future management of resistant hypertension
Elijovich, Fernando
KIDNEY INTERNATIONAL, 2022, 101 (01) : 6 - 9
[42] Recent trends in renal denervation devices for resistant hypertension treatment
Haribabu, Sumeeyae
Sharif, Faisal
Zafar, Haroon
IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 971 - 979
[43] Current management of neuroblastoma and future direction
Pastor, Elizabeth R.
Mousa, Shaker A.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 138 : 38 - 43
[44] Current and future direction in the management of scleroderma
Sean M. Brady
Lee Shapiro
Shaker A. Mousa
Archives of Dermatological Research, 2016, 308 : 461 - 471
[45] Current and future direction in the management of scleroderma
Brady, Sean M.
Shapiro, Lee
Mousa, Shaker A.
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2016, 308 (07) : 461 - 471
[46] Renal denervation. Current state and future perspectives
Kara, K.
Bruck, H.
Kahlert, P.
Plicht, B.
Mahabadi, A. A.
Konorza, T.
Erbel, R.
HERZ, 2012, 37 (07) : 746 - 753
[47] Treating Hypertension Using Renal Artery Denervation: Problems and Progress
Townsend, Raymond R.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (02) : 117 - 121
[48] Management of Arterial Hypertension: From No Treatment to Renal Denervation
Stefanadis, Christodoulos I.
HELLENIC JOURNAL OF CARDIOLOGY, 2015, 56 (03) : 277 - 278
[49] Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension
Calhoun, David A.
CIRCULATION, 2016, 134 (12) : 858 - 860
[50] The effects of renal artery diameter in patients with resistant hypertension by renal sympathetic denervation
Xu Youlong
Jin Huigen
Gao Junqing
Yan Penyong
Zhang Wenquan
Wang Mingyu
Liu Zongjun
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C177 - C177

← 1 2 3 4 5 →